Indefinite Delivery Contract 36C26226D0063
Award Date 3/20/26
Last Date to Order 3/19/31
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Roche Diagnostics Corporation has been awarded a single-award Indefinite Delivery Contract with a ceiling value of $33.8M by Veterans Integrated Service Network 22 (VISN 22), a civilian component of the Department of Veterans Affairs. The contract, awarded September 26, 2024, with an ultimate completion date of September 25, 2029, procures a comprehensive Chemistry/Immunoassay System solution including instrumentation, reagents, supplies, and associated laboratory testing services for VA medical...
- Roche Diagnostics Corporation has been awarded an Indefinite Delivery Contract by the Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), with a ceiling value of $167,300.00 and an ultimate completion date of June 30, 2030. The contract was awarded on July 1, 2025, without set-aside designation, reflecting open competition in the federal marketplace. Under this IDV, Roche will supply Roche LIAT consumables for rapid molecular diagnostic testing, specifically test kits...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory instruments, was awarded a Federal Supply Schedule contract by the Department of Veterans Affairs, Veterans Integrated Service Network 12, on March 16, 2017, with an ultimate completion date of March 15, 2027. This multiple-award, open competition contract carries a ceiling value of $260,000,000.01 and was established under the General Services Administration's Critical Analyzers,...
- Roche Diagnostics Corporation received an indefinite delivery contract award from the Department of Veterans Affairs Veterans Integrated Service Network 2 (VISN 2) on March 20, 2025, with a ceiling value of $417,376.70 and ultimate completion date of March 31, 2030. The contract, awarded without set-aside designation under open competition, provides instrument consumables and reagents for the Hudson Valley VA Medical Center in Wappingers Falls, New York, with products sourced from Roche...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide laboratory testing supplies and equipment. The IDV has a potential value of $6.5 million and period of performance through June 2027. Three delivery orders have been issued against the contract to date for a total of $246,135.04, $231,704.12, and $13,824 for reagents, supplies, and molecular testing systems...
- Roche Diagnostics Corporation has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs Veterans Integrated Service Network 6 (VISN 6) with a ceiling value of $4.93 million and an ultimate completion date of September 30, 2026. The contract, which commenced on October 1, 2025, procures histology consumables, test kits, reagents, and supplies to support diagnostic laboratory operations across six VA Medical Center facilities (Hampton, Durham, Richmond,...
- Roche Diagnostics Corporation has been awarded a single-award Blanket Purchase Agreement (BPA) by Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs, for molecular pathology Current Procedural Terminology (CPT) services. The contract carries a ceiling value of $4.29 million with a performance period extending from April 1, 2026, through March 31, 2027. No set-aside designation was utilized in this competitive award. The BPA was...
- Roche Diagnostics Corporation has been awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs' Veterans Integrated Service Network 1 to supply point-of-care coagulation testing equipment, supplies, reagents, network connections, service, maintenance, and parts. The contract, valued at $469,000 with a period of performance from May 1, 2025 through April 30, 2030, was issued as a sole-source procurement under Federal Acquisition Regulation 6.302-1-1, as...
- Roche Diagnostics Corporation received a single-award Blanket Purchase Agreement from Veterans Integrated Service Network 10 (VISN 10), a civilian component of the Department of Veterans Affairs, valued at $630,030.40 with an ultimate completion date of February 4, 2026. The contract, established without set-aside designation through the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) Master Schedule, procures human papillomavirus (HPV) testing equipment,...
- Roche Diagnostics Corporation was awarded a five-year Federal Supply Schedule contract (FSS-65-VII) for In Vitro Diagnostics, Reagents, Test Kits, and Test Sets, effective May 15, 2022, through May 14, 2027, with a ceiling value of $32.5 million. This multiple-award contract, funded by Veterans Integrated Service Network 12 under the Department of Veterans Affairs, represents an unrestricted procurement with no set-aside designation. The contract encompasses a comprehensive portfolio of...